---
title: "Gilead Sciences Inc. Stock Underperforms Friday When Compared To Competitors"
description: "Gilead Sciences Inc. (GILD) stock fell 1.31% to $125.84 on Friday, underperforming compared to competitors. The S&P 500 Index rose 0.54% and the Dow Jones Industrial Average rose 0.61%. Gilead's stock"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/267891060.md"
published_at: "2025-11-28T21:35:34.000Z"
---

# Gilead Sciences Inc. Stock Underperforms Friday When Compared To Competitors

> Gilead Sciences Inc. (GILD) stock fell 1.31% to $125.84 on Friday, underperforming compared to competitors. The S&P 500 Index rose 0.54% and the Dow Jones Industrial Average rose 0.61%. Gilead's stock ended a two-day winning streak and closed 2.22% below its 52-week high. Trading volume was 3.1 million, below the 50-day average of 7.6 million.

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Gilead Sciences Inc. (GILD) slid 1.31% to $125.84 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.54% to 6,849.09 and the Dow Jones Industrial Average rising 0.61% to 47,716.42. The stock's fall snapped a two-day winning streak. Gilead Sciences Inc. closed 2.22% below its 52-week high of $128.70, which the company reached on November 20th. The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson (JNJ) fell 0.31% to $206.92, Pfizer Inc. (PFE) rose 0.12% to $25.74, and Abbott Laboratories (ABT) rose 0.28% to $128.90. Trading volume (3.1 M) remained 4.5 million below its 50-day average volume of 7.6 M. Data source: Dow Jones Market Data, FactSet. Data compiled November 28, 2025. This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. (END) Dow Jones Newswires 11-28-25 1635ET

### Related Stocks

- [GILD.US - Gilead Sciences](https://longbridge.com/en/quote/GILD.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| P/E Ratio Insights for Gilead Sciences | Gilead Sciences Inc. (NASDAQ:GILD) stock is currently priced at $147.00, reflecting a 1.31% decrease. Despite this, the  | [Link](https://longbridge.com/en/news/277254163.md) |
| Gilead Sciences, Inc. $GILD Shares Sold by DNB Asset Management AS | DNB Asset Management AS reduced its stake in Gilead Sciences, Inc. by 15.3% in Q3, now holding 245,117 shares valued at  | [Link](https://longbridge.com/en/news/277298699.md) |
| Argent Trust Co Buys 21,785 Shares of Gilead Sciences, Inc. $GILD | Argent Trust Co increased its stake in Gilead Sciences, Inc. by 32.2% in Q3, acquiring 21,785 shares, bringing its total | [Link](https://longbridge.com/en/news/277291042.md) |
| Is Cisco Systems Stock Outperforming the Dow? | Is Cisco Systems Stock Outperforming the Dow? | [Link](https://longbridge.com/en/news/276887838.md) |
| 11:07 ETLAVERNE COX & AMBER RILEY JOIN THE ELIZABETH TAYLOR AIDS FOUNDATION AHEAD OF FEB. 28 HIV IS NOT A CRIME AWARENESS DAY | The Elizabeth Taylor AIDS Foundation (ETAF) marks HIV IS NOT A CRIME Awareness Day, advocating for the modernization of  | [Link](https://longbridge.com/en/news/277225639.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.